GSK is investing £45m with the Fleming Initiative to launch six research programmes using cutting-edge AI to tackle antimicrobial resistance ...
Drugmaker GlaxoSmithKline entered into a four-year collaboration with 23andMe to use human genetics to guide drug development, investing $300M in the direct-to-consumer genetic testing company to fund ...
HAMILTON - Thirty years ago, four Bitterroot scientists had a dream. They believed that hidden away in the cell wall of a certain bacteria, there were all the components necessary to produce a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback